RCEL

#3760
Avita Medical, Inc. Common Stock
5.60 USD
+14.05%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
5.60
5.60
Intervallo Annuale
3.22
10.29
Variazione giornaliera
+14.05%
Variazione Mensile
+21.21%
Variazione di 6 mesi
+6.87%
Variazione Annuale
-35.33%
Chiusura Precedente
4.91
Apertura
5.60
Bid
Ask
Minimo
5.60
High
5.60
Volume
22
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 171.54 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.98
Rapporto prezzo/fatturato
1.34

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

Notizie